Literature DB >> 30989079

Giant Congenital Sialolipoma of Parotid Gland with Parapharyngeal Extension.

Taner-Kemal Erdağ1, Yüksel Olgun1, Melih-Arif Közen1, Handan Güleryüz2, Erdener Özer3.   

Abstract

INTRODUCTION: Sialolipoma is an extremely rare salivary gland tumor characterized by a well circumscribed mass composed of glandular tissue and mature adipose elements. Herein our aim was to present the fifth case of congenital sialolipoma, which was firstly followed up as a parotid gland hemangioma, and underline the fact that sialolipomas should be kept in mind in the differential diagnosis of congenital parotid gland masses. CASE REPORT: A 10-month old male presented with a left-sided huge neck mass which progressed after birth. Radiologic examination revealed a tumor originating from the parotid gland filling the parapharyngeal space. Histopathologic examination of an incisional biopsy was consistent with sialolipoma. A total parotidectomy with preservation of the facial nerve was performed at the age of 1 year. The postoperative recovery was uneventful with normal facial nerve function. There was no recurrence at the 24-month follow-up.
CONCLUSION: Although it is a very rare benign tumor, congenital sialolipoma should be kept in mind in the differential diagnosis of congenital parotid mass.

Entities:  

Keywords:  Congenital; Parotid; Sialolipoma

Year:  2019        PMID: 30989079      PMCID: PMC6449526     

Source DB:  PubMed          Journal:  Iran J Otorhinolaryngol        ISSN: 2251-7251


Introduction

Sialolipoma was firstly described by Nagao et al. as a new type of benign salivary gland neoplasm characterized by a well circumscribed mass composed of glandular tissue and mature adipose elements (1). Although commonly seen in the parotid gland, sialolipoma may also arise from submandibular gland, as well as minor salivary glands (2–8). It constitutes only 0.3% of all salivary gland tumors in adults, and more than 40 cases of sialolipoma have been reported in the English literature (1,3). Congenital sialolipoma is an extremely rare tumor, and the first case was reported by Hornigold et al. in 2005 in a 7-week-old infant as a parotid gland mass (2). Three more congenital sialolipoma cases arising from the parotid gland have subsequently been described (2–4). Herein our aim was to present the fifth case of congenital sialolipoma, which was firstly followed up as a parotid gland hemangioma, and underline the fact that sialolipomas should be kept in mind in the differential diagnosis of congenital parotid gland masses.

Case Report

A 3-month-old male was seen in our pediatric oncology department because of a growing parotid gland mass. The mass was congenital and was followed by the pediatric oncology team with a prediagnosis of hemangioma. The patient’s magnetic resonance imaging (MRI) scan showed an infantile hemangioma in the proliferative phase filling the parapharyngeal space (Fig.1a,b).
Fig 1

a) Neck MRI, T2-weighted axial image; b) contrast enhanced image showing left-sided hyperintense mass lesion with contrast enhancement

a) Neck MRI, T2-weighted axial image; b) contrast enhanced image showing left-sided hyperintense mass lesion with contrast enhancement The child then received propranolol therapy, but despite this treatment the mass continued to grow, and the child was referred to our department at the age of 10 months. The otorhinolaryngological examination revealed an 8×7-cm mass filling the left parotid region, with normal facial nerve motor functions (Fig.2). Histopathological diagnosis of the mass was provided by an incisional biopsy as sialolipoma.
Fig 2

Patients preoperative otorhinolaryngological examination revealed an 8 x 7 cm mass filling the left parotid region

Patients preoperative otorhinolaryngological examination revealed an 8 x 7 cm mass filling the left parotid region We planned to perform total excision of the mass with a transparotid approach. The facial nerve was monitored intra-operatively, and surgery was performed under magnification using surgical loops. A standard modified Blair incision was used, flaps were raised (Fig.3), then the facial nerve was identified in a standard fashion using a tragal pointer and posterior belly of the digastric muscle as landmarks.
Fig 3

Giant mass arising from the parotid gland after elevation of the flaps

Giant mass arising from the parotid gland after elevation of the flaps The main trunk of the facial nerve was found to be unusually elongated before pes anserinus. A soft lobular mass was encountered. A tumor involving the superficial parotid lobe was first dissected, then the deep lobe of the parotid gland and portion of the tumor filling the parapharyngeal space were gently dissected under the facial nerve (Fig.4). A Jackson-Pratt drain was inserted into the wound after the excision of the tumor.
Fig 4

The main trunk of the facial nerve was found to be unusually elongated before the pes anserinus. After dissection of the portion of the tumor involving superficial parotid lobe, the deep lobe of the parotid gland and portion of the tumor filling the parapharyngeal space was encountered

The main trunk of the facial nerve was found to be unusually elongated before the pes anserinus. After dissection of the portion of the tumor involving superficial parotid lobe, the deep lobe of the parotid gland and portion of the tumor filling the parapharyngeal space was encountered On macroscopic examination, the mass was found to be a lipomatous specimen, 9×8×4 cm in size. The cut surface was consistent with the appearance of a lipoma. Histopathologic examination confirmed the diagnosis of a sialolipoma. The lesion was composed of mature adipose tissue mixed with acinar, ductal structures of a normal salivary gland (Fig.5).
Fig 5

The lesion was composed of mature adipose tissue mixed with acinar and ductal structures of a salivary gland and lymphoid infiltrate. H&E staining, ×100

The lesion was composed of mature adipose tissue mixed with acinar and ductal structures of a salivary gland and lymphoid infiltrate. H&E staining, ×100 The postoperative period was uneventful. The patient’s facial nerve motor functions were well preserved, and he was discharged on the third postoperative day. The patient is still followed, and has no signs of recurrence in his 24th postoperative month.

Discussion

The term sialolipoma was first used by Nagao et al. when they described seven sialolipoma cases in their retrospective analysis of the 2,051 primary salivary gland tumor specimens (1). In 2005, the term sialolipoma was accepted in the World Health Organization (WHO) classification of head and neck tumors (9). Sialolipoma is a mixed tumor consisting of salivary gland elements and mature adipocytes (1,2,9). Usually it is seen as a lobular tumor, which is similar to our case, and histopathologically it may show lobules with rich and fatty components surrounding the salivary elements (9). The majority of sialolipomas are seen in the parotid region, but the submandibular gland and other minor salivary glands may be the site of origin in some cases (2–8). To date, more than 40 cases of sialolipomas have been presented, but the majority are in adult patients. Sialolipoma in children is extremely rare, with only four congenital cases depicted to date (2–5). To the best of our knowledge, our case is the fifth case of congenital sialolipoma. Interestingly, all congenital cases were derived from the parotid gland. In addition, two non-congenital sialolipoma cases arising from the submandibular and parotid glands have been described in two 3-year-old children (6,10). The most common congenital tumor of the parotid gland is hemangioma, although branchial cleft cyst, cystic hygroma, and sialoblastoma are among other congenital masses that can be seen in this period (2,4). Our patient presented with a rapidly growing congenital parotid swelling and was given an initial diagnosis of hemangioma in the proliferative phase based on MRI findings (increased signal on T2 weighted series and homogenous contrast enhancement of the mass). Despite propranolol treatment, the mass continued to grow, so we performed an incisional biopsy which was described as sialolipoma. The efficacy of MRI for differentiating sialolipoma from other congenital parotid gland masses is not adequate, but it can give information on the extent of the lesion (4). Fine needle aspiration biopsy is usually not helpful in cases of sialolipoma (3,4). Preoperative diagnosis can be obtained by US-guided core or incisional biopsies. Parotidectomy in small children may present some difficulties. First of all, anatomical structures are much smaller, the facial nerve is located relatively superficially in comparison with adult patients, and the mastoid process is not fully developed. Consequently, operating under magnification with surgical loops or microscopes is mandatory, and facial nerve monitoring may facilitate identification of the nerve. In our case, the main trunk of the facial nerve was found to be 5 cm, unusually elongated before the pes anserinus. We believe that this finding was due to pressure and the stretching effect of the giant tumor. Similar surgical findings were also reported by Kidambi et al (4). Complete surgical excision (total or superficial parotidectomy) with facial nerve preservation is the treatment of choice, and no recurrence has been reported in the literature regarding congenital sialolipomas. Our case was also followed for 24 months without any signs of recurrence.

Conclusion

Although very rarely encountered, congenital sialolipomas should be kept in mind for the differential diagnosis of congenital parotid masses. Definitive treatment of this tumor is obtained with superficial/total parotidectomy depending on the extent of the lesion.
  10 in total

Review 1.  Congenital sialolipoma of parotid gland: a report of rare and recently described entity with review of literature.

Authors:  Bhavna Bansal; Anurag S Ramavat; Sampada Gupta; Sompal Singh; Amitabh Sharma; Kusum Gupta; A K Mittal; Madhur Kudesia
Journal:  Pediatr Dev Pathol       Date:  2007 May-Jun

2.  Congenital sialolipoma of the parotid gland: presentation, diagnosis, and management.

Authors:  Trilokesh Kidambi; Mark J Been; John Maddalozzo
Journal:  Am J Otolaryngol       Date:  2011-09-13       Impact factor: 1.808

3.  Sialolipoma of minor salivary glands: presentation of five cases and review of the literature with an epidemiological analyze.

Authors:  Elba Leyva Huerta; Daniel Quezada Rivera; Fernando Tenorio Rocha; José Luis Tapia; Javier Portilla Robertson; Luis Alberto Gaitán Cepeda
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-11-01

4.  Sialolipoma of the parotid gland with diffuse sebaceous differentiation in a female child.

Authors:  Maryam Kadivar; Shahriar Zohourian Shahzadi; Morteza Javadi
Journal:  Pediatr Dev Pathol       Date:  2007 Mar-Apr

5.  Sialolipoma: a report of seven cases of a new variant of salivary gland lipoma.

Authors:  T Nagao; I Sugano; Y Ishida; A Asoh; S Munakata; K Yamazaki; A Konno; Y Kondo; K Nagao
Journal:  Histopathology       Date:  2001-01       Impact factor: 5.087

Review 6.  Congenital sialolipoma of the parotid gland first reported case and review of the literature.

Authors:  R Hornigold; P R Morgan; A Pearce; M J Gleeson
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2004-12-15       Impact factor: 1.675

Review 7.  Fat-containing salivary gland tumors: a review.

Authors:  Abbas Agaimy
Journal:  Head Neck Pathol       Date:  2013-07-03

8.  Sialolipoma of the submandibular gland in a child.

Authors:  Kaori Sato; Chikashi Gotoh; Hiroo Uchida; Hiroshi Kawashima; Mariko Yoshida; Yoshihiro Kitano; Hiroshi Kishimoto
Journal:  J Pediatr Surg       Date:  2011-02       Impact factor: 2.545

9.  Congenital Sialolipoma in an Infant.

Authors:  Muhammed Recai Mazlumoglu; Enver Altas; Fatih Oner; Harun Ucuncu; Muhammed Calik
Journal:  J Craniofac Surg       Date:  2015-11       Impact factor: 1.046

10.  Sialolipoma of the parotid gland.

Authors:  Sedat Doğan; Ilknur Haberal Can; Ilhan Unlü; Nuran Süngü; Mehmet Alparslan Gönültaş; Ethem Erdal Samim
Journal:  J Craniofac Surg       Date:  2009-05       Impact factor: 1.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.